APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Insulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Insulin Industry Growth and Trends Forecast to 2032

Report ID 173999900120 December 2025107 pages

Choose your research edition.

Industry ResearchHuman Insulin Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Insulin Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Human Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Insulin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Insulin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Human Insulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Insulin include Sanofi, ELI Lilly, B. Braun, Ypsomed, Wockhardt, NOVO Nordisk, Julphar, Biodel and Biocon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Insulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Insulin market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Insulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Insulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Insulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Insulin Market by Company

Sanofi

ELI Lilly

B. Braun

Ypsomed

Wockhardt

NOVO Nordisk

Julphar

Biodel

Biocon

Becton, Dickinson

Human Insulin Segment by Type

Insulin Analogs and Biosimilars

Human Insulin Biologics

Human Insulin Segment by Application

Short Acting

Pre-Mix Insulin

Long Acting

Intermediate Acting

Human Insulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Insulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulin Analogs and Biosimilars Table 2. Major Company of Human Insulin Biologics Table 3. Global Human Insulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Insulin Sales by Type (2021-2026) & (W Units) Table 5. Global Human Insulin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Insulin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Insulin Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Insulin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Human Insulin Sales by Type (2027-2032) & (W Units) Table 10. Global Human Insulin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Insulin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Insulin Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Insulin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Human Insulin Sales by Type (2021-2026) & (W Units) Table 15. North America Human Insulin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Insulin Sales by Type (2021-2026) & (W Units) Table 17. Europe Human Insulin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Insulin Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Human Insulin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Insulin Sales by Type (2021-2026) & (W Units) Table 21. Latin America Human Insulin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Insulin Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Human Insulin Sales by Type (2021-2026) & (US$ Million) Table 24. Human Insulin Industry Trends Table 25. Human Insulin Industry Drivers Table 26. Human Insulin Industry Opportunities and Challenges Table 27. Human Insulin Industry Restraints Table 28. Global Human Insulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Insulin Revenue Market Share by Company (2021-2026) Table 30. Global Human Insulin Sales by Company (2021-2026) & (W Units) Table 31. Global Human Insulin Sales Share by Company (2021-2026) Table 32. Global Human Insulin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Human Insulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Insulin Major Company Production Sites and Headquarters Table 35. Global Human Insulin Company, Product Type & Application Table 36. Global Human Insulin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Insulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Insulin Sales by Region (2021-2026) & (W Units) Table 41. Global Human Insulin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Insulin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Insulin Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Insulin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Human Insulin Sales by Region (2027-2032) & (W Units) Table 46. Global Human Insulin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Insulin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Insulin Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Insulin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Human Insulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Insulin Sales by Application (2021-2026) & (W Units) Table 52. Global Human Insulin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Insulin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Insulin Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Insulin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Human Insulin Sales by Application (2027-2032) & (W Units) Table 57. Global Human Insulin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Insulin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Insulin Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Insulin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Human Insulin Sales by Application (2021-2026) & (W Units) Table 62. North America Human Insulin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Insulin Sales by Application (2021-2026) & (W Units) Table 64. Europe Human Insulin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Insulin Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Human Insulin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Insulin Sales by Application (2021-2026) & (W Units) Table 68. Latin America Human Insulin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Insulin Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Human Insulin Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Human Insulin Product Portfolio Table 75. Sanofi Recent Development Table 76. ELI Lilly Company Information Table 77. ELI Lilly Business Overview Table 78. ELI Lilly Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. ELI Lilly Human Insulin Product Portfolio Table 80. ELI Lilly Recent Development Table 81. B. Braun Company Information Table 82. B. Braun Business Overview Table 83. B. Braun Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. B. Braun Human Insulin Product Portfolio Table 85. B. Braun Recent Development Table 86. Ypsomed Company Information Table 87. Ypsomed Business Overview Table 88. Ypsomed Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ypsomed Human Insulin Product Portfolio Table 90. Ypsomed Recent Development Table 91. Wockhardt Company Information Table 92. Wockhardt Business Overview Table 93. Wockhardt Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Wockhardt Human Insulin Product Portfolio Table 95. Wockhardt Recent Development Table 96. NOVO Nordisk Company Information Table 97. NOVO Nordisk Business Overview Table 98. NOVO Nordisk Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. NOVO Nordisk Human Insulin Product Portfolio Table 100. NOVO Nordisk Recent Development Table 101. Julphar Company Information Table 102. Julphar Business Overview Table 103. Julphar Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Julphar Human Insulin Product Portfolio Table 105. Julphar Recent Development Table 106. Biodel Company Information Table 107. Biodel Business Overview Table 108. Biodel Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Biodel Human Insulin Product Portfolio Table 110. Biodel Recent Development Table 111. Biocon Company Information Table 112. Biocon Business Overview Table 113. Biocon Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Biocon Human Insulin Product Portfolio Table 115. Biocon Recent Development Table 116. Becton, Dickinson Company Information Table 117. Becton, Dickinson Business Overview Table 118. Becton, Dickinson Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Becton, Dickinson Human Insulin Product Portfolio Table 120. Becton, Dickinson Recent Development Table 121. North America Human Insulin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. North America Human Insulin Sales by Country (2021-2026) & (W Units) Table 123. North America Human Insulin Sales Market Share by Country (2021-2026) Table 124. North America Human Insulin Sales Forecast by Country (2027-2032) & (W Units) Table 125. North America Human Insulin Sales Market Share Forecast by Country (2027-2032) Table 126. North America Human Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Human Insulin Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Human Insulin Market Share by Country (2021-2026) Table 129. North America Human Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Human Insulin Market Share Forecast by Country (2027-2032) Table 131. Europe Human Insulin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Europe Human Insulin Sales by Country (2021-2026) & (W Units) Table 133. Europe Human Insulin Sales Market Share by Country (2021-2026) Table 134. Europe Human Insulin Sales Forecast by Country (2027-2032) & (W Units) Table 135. Europe Human Insulin Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Human Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Human Insulin Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Human Insulin Market Share by Country (2021-2026) Table 139. Europe Human Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Human Insulin Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Human Insulin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Human Insulin Sales by Country (2021-2026) & (W Units) Table 143. Asia-Pacific Human Insulin Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Human Insulin Sales Forecast by Country (2027-2032) & (W Units) Table 145. Asia-Pacific Human Insulin Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Human Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Human Insulin Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Human Insulin Market Share by Country (2021-2026) Table 149. Asia-Pacific Human Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Human Insulin Market Share Forecast by Country (2027-2032) Table 151. Latin America Human Insulin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Latin America Human Insulin Sales by Country (2021-2026) & (W Units) Table 153. Latin America Human Insulin Sales Market Share by Country (2021-2026) Table 154. Latin America Human Insulin Sales Forecast by Country (2027-2032) & (W Units) Table 155. Latin America Human Insulin Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Human Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Human Insulin Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Human Insulin Market Share by Country (2021-2026) Table 159. Latin America Human Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Human Insulin Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Human Insulin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Human Insulin Sales by Country (2021-2026) & (W Units) Table 163. Middle East and Africa Human Insulin Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Human Insulin Sales Forecast by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Human Insulin Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Human Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Human Insulin Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Human Insulin Market Share by Country (2021-2026) Table 169. Middle East and Africa Human Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Human Insulin Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Human Insulin Distributors List Table 174. Human Insulin Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Human Insulin Image Figure 2. Global Human Insulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Insulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Insulin Sales (2021-2032) & (W Units) Figure 5. Insulin Analogs and Biosimilars Image Figure 6. Global Insulin Analogs and Biosimilars Sales YoY Growth (2021-2032) & (W Units) Figure 7. Human Insulin Biologics Image Figure 8. Global Human Insulin Biologics Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Human Insulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Insulin Market Share by Type 2025 VS 2032 Figure 11. North America Human Insulin Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Insulin Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Insulin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Insulin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Insulin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Insulin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Insulin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Insulin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Insulin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Insulin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Insulin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Short Acting Image Figure 24. Global Short Acting Sales YoY Growth (2021-2032) & (W Units) Figure 25. Pre-Mix Insulin Image Figure 26. Global Pre-Mix Insulin Sales YoY Growth (2021-2032) & (W Units) Figure 27. Long Acting Image Figure 28. Global Long Acting Sales YoY Growth (2021-2032) & (W Units) Figure 29. Intermediate Acting Image Figure 30. Global Intermediate Acting Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Human Insulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Human Insulin Market Share by Application 2025 VS 2032 Figure 33. North America Human Insulin Sales Market Share in Volume by Application in 2025 Figure 34. North America Human Insulin Sales Market Share in Value by Application in 2025 Figure 35. Europe Human Insulin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Human Insulin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Human Insulin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Human Insulin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Human Insulin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Human Insulin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Human Insulin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Human Insulin Sales Market Share in Value by Application in 2025 Figure 43. North America Human Insulin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Human Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Human Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Human Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Insulin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Human Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Human Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Insulin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Human Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Human Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Insulin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Human Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Human Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Insulin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Human Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Human Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Human Insulin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Human Insulin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Analogs and Biosimilars
  • Human Insulin Biologics
Applications
  • Short Acting
  • Pre-Mix Insulin
  • Long Acting
  • Intermediate Acting
Companies covered
  • Sanofi
  • ELI Lilly
  • B. Braun
  • Ypsomed
  • Wockhardt
  • NOVO Nordisk
  • Julphar
  • Biodel
  • Biocon
  • Becton, Dickinson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Insulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Insulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Insulin Market by Type
  6. 1.3.1 Insulin Analogs and Biosimilars
  7. 1.3.2 Human Insulin Biologics
  8. 1.4 Global Human Insulin Market Size by Type
  9. 1.4.1 Global Human Insulin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Insulin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Insulin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Insulin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Insulin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Insulin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Insulin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Insulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Insulin Industry Trends
  2. 2.2 Human Insulin Industry Drivers
  3. 2.3 Human Insulin Industry Opportunities and Challenges
  4. 2.4 Human Insulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Insulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Insulin Sales (2021-2026)
  3. 3.3 Global Top Players by Human Insulin Price (2021-2026)
  4. 3.4 Global Human Insulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Insulin Major Company Production Sites & Headquarters
  6. 3.6 Global Human Insulin Company, Product Type & Application
  7. 3.7 Global Human Insulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Insulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Insulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Insulin Tier 1, Tier 2, and Tier 3
4 Human Insulin Regional Status and Outlook
  1. 4.1 Global Human Insulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Insulin Historic Market Size by Region
  3. 4.2.1 Global Human Insulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Insulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Insulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Insulin Forecasted Market Size by Region
  7. 4.3.1 Global Human Insulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Insulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Insulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Insulin by Application
  1. 5.1 Human Insulin Market by Application
  2. 5.1.1 Short Acting
  3. 5.1.2 Pre-Mix Insulin
  4. 5.1.3 Long Acting
  5. 5.1.4 Intermediate Acting
  6. 5.2 Global Human Insulin Market Size by Application
  7. 5.2.1 Global Human Insulin Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Human Insulin Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Human Insulin Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Human Insulin Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Human Insulin Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Human Insulin Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Human Insulin Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Human Insulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Human Insulin Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 ELI Lilly
  8. 6.2.1 ELI Lilly Company Information
  9. 6.2.2 ELI Lilly Business Overview
  10. 6.2.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ELI Lilly Human Insulin Product Portfolio
  12. 6.2.5 ELI Lilly Recent Developments
  13. 6.3 B. Braun
  14. 6.3.1 B. Braun Company Information
  15. 6.3.2 B. Braun Business Overview
  16. 6.3.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 B. Braun Human Insulin Product Portfolio
  18. 6.3.5 B. Braun Recent Developments
  19. 6.4 Ypsomed
  20. 6.4.1 Ypsomed Company Information
  21. 6.4.2 Ypsomed Business Overview
  22. 6.4.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ypsomed Human Insulin Product Portfolio
  24. 6.4.5 Ypsomed Recent Developments
  25. 6.5 Wockhardt
  26. 6.5.1 Wockhardt Company Information
  27. 6.5.2 Wockhardt Business Overview
  28. 6.5.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Wockhardt Human Insulin Product Portfolio
  30. 6.5.5 Wockhardt Recent Developments
  31. 6.6 NOVO Nordisk
  32. 6.6.1 NOVO Nordisk Company Information
  33. 6.6.2 NOVO Nordisk Business Overview
  34. 6.6.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NOVO Nordisk Human Insulin Product Portfolio
  36. 6.6.5 NOVO Nordisk Recent Developments
  37. 6.7 Julphar
  38. 6.7.1 Julphar Company Information
  39. 6.7.2 Julphar Business Overview
  40. 6.7.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Julphar Human Insulin Product Portfolio
  42. 6.7.5 Julphar Recent Developments
  43. 6.8 Biodel
  44. 6.8.1 Biodel Company Information
  45. 6.8.2 Biodel Business Overview
  46. 6.8.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biodel Human Insulin Product Portfolio
  48. 6.8.5 Biodel Recent Developments
  49. 6.9 Biocon
  50. 6.9.1 Biocon Company Information
  51. 6.9.2 Biocon Business Overview
  52. 6.9.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Biocon Human Insulin Product Portfolio
  54. 6.9.5 Biocon Recent Developments
  55. 6.10 Becton, Dickinson
  56. 6.10.1 Becton, Dickinson Company Information
  57. 6.10.2 Becton, Dickinson Business Overview
  58. 6.10.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Becton, Dickinson Human Insulin Product Portfolio
  60. 6.10.5 Becton, Dickinson Recent Developments
7 North America by Country
  1. 7.1 North America Human Insulin Sales by Country
  2. 7.1.1 North America Human Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Insulin Sales by Country (2021-2026)
  4. 7.1.3 North America Human Insulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Insulin Market Size by Country
  6. 7.2.1 North America Human Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Insulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Insulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Insulin Sales by Country
  2. 8.1.1 Europe Human Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Insulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Insulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Insulin Market Size by Country
  6. 8.2.1 Europe Human Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Insulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Insulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Insulin Sales by Country
  2. 9.1.1 Asia-Pacific Human Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Insulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Insulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Insulin Market Size by Country
  6. 9.2.1 Asia-Pacific Human Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Insulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Insulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Insulin Sales by Country
  2. 10.1.1 South America Human Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Insulin Sales by Country (2021-2026)
  4. 10.1.3 South America Human Insulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Insulin Market Size by Country
  6. 10.2.1 South America Human Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Insulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Insulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Insulin Sales by Country
  2. 11.1.1 Middle East and Africa Human Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Insulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Insulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Insulin Market Size by Country
  6. 11.2.1 Middle East and Africa Human Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Insulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Insulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Insulin Value Chain Analysis
  2. 12.1.1 Human Insulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Insulin Production Mode & Process
  7. 12.2 Human Insulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Insulin Distributors
  10. 12.2.3 Human Insulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst